AI tools are revolutionizing neuroscience, enabling researchers to predict study outcomes with 86% accuracy and uncover novel ...

Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...

Michael W. Schwartz UW Medicine Diabetes Institute, explains how the brain can be targeted to treat obesity and diabetes ...

Prof of Neuroscience Jeffrey W. Dalley said the gift would be "truly transformative" in accelerating research efforts to ...

When listeners detect excessive filler words, the brain's amygdala activates a subtle "threat" response, signaling uncertainty or or unreliability in the speaker.

WATERTOWN, Mass. - Vigil Neuroscience , Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company, has announced the progression of its Alzheimer’s disease (AD) candidate, VG-3927, into a Phase 2 ...

Wildlife rehabilitation programs play a crucial role in rescuing, treating, and preparing injured or orphaned animals for ...

The last several decades produced revolutionary advances in two areas: identifying neuronal processes responsible for intelligence and designing machine ...

Neuromorphic computing -- a field that applies principles of neuroscience to computing systems to mimic the brain's function and structure -- needs to scale up if it is to effectively compete with ...

Adults with ADHD might die up to 11 years earlier than those without the disorder, a first-of-its-kind study has found, as ...

News and politics tap into our fears, which can overwhelm our nervous systems. Here’s how to channel that energy for the better.

AdventHealth Georgia is pleased to announce the appointment of Riley Benter as the new director of heart and vascular ...